contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


idex-biometrics-asa-conversion-of-bonds-and-share-capital-increase

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

IDEX Biometrics is a Norwegian technology company focused on developing and commercializing products within advanced sensor technology used in fingerprint reading. The company's products are used in a variety of biometric enabled devices in markets such as mobile phones, smart cards, and in the IoT (Internet of Things) segment. The company was founded in 1996 and is headquartered in Oslo.

IDEX Biometrics

Reference is made to the convertible bond agreement with CVI Investments, Inc. dated 22 December 2023 (as amended 16 May 2025).On 9 January 2026, IDEX Biometrics ASA received a Conversion Notice...

<div class="mfn-preamble"><p><strong>Reference is made to the convertible bond agreement with CVI Investments, Inc. dated 22 December 2023 (as amended 16 May 2025).</strong></p></div><div class="mfn-body"><p>On 9 January 2026, IDEX Biometrics ASA received a Conversion Notice from CVI Investments, Inc. to convert 15 bonds with a total value of NOK 4,998,000 at a conversion price of NOK 6.50 per share.</p><p>Following the conversion, the Company's share capital increases by NOK 768,923 from NOK 62,600,677 to NOK 63,369,600 through the issuance of 768,923 new shares to CVI Investments, Inc. The Company's share capital is now NOK 63,369,600 divided into 63,369,600 shares, each with a nominal value of NOK 1.00.</p></div><div class="mfn-footer mfn-contacts mfn-0db42943cf4b"><p><strong class="mfn-heading-1">Contacts</strong><br>Anders Storbråten, CEO and CFO, Tel: +47&nbsp;416 38 582<br>E-mail:&nbsp;<a rel="noopener" href="mailto:ir@idexbiometrics.com">ir@idexbiometrics.com</a></p></div><div class="mfn-footer mfn-about mfn-aa20e3fea228"><p><strong class="mfn-heading-1">About Us</strong><br>IDEX Biometrics ASA (OSE: IDEX) is shaping the future of access and payments.</p><p>IDEX Biometrics is advancing the future of access and payments with identity-first biometrics. With over a decade of proprietary innovation, our solutions are proven in the field, globally certified, and trusted by leading financial institutions. We serve enterprises, the public sector, banks, and issuers directly and through partners, delivering secure, seamless experiences in digital and physical access and payments.<br> <br>For more information, visit&nbsp;<a rel="noopener" href="http://www.idexbiometrics.com/">www.idexbiometrics.com</a></p></div><div class="mfn-footer mfn-regulatory mfn-regulatory-nsta"><p><em>This information is subject to disclosure under the Norwegian Securities Trading Act, §5-12. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-01-12 07:00 CET.</em></p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong><br><a rel="noopener" href="https://storage.mfn.se/4dcbe66a-6a3b-4ed6-b0ce-459b5f6e7182/idex-biometrics-asa-conversion-of-bonds-and-share-capital-increase.pdf" class="mfn-generated mfn-primary">IDEX Biometrics ASA: Conversion of bonds and share capital increase</a></p></div>

IDEX Biometrics ASA: Conversion of bonds and share capital increase

Faron Pharmaceuticals

Herantis Pharma

Mendus

Probabilities of success in drug development

Financial Key Ratios: EV/EBIT, EV/EBITA, EV/EBITDA, and EV/Sales

Solar Foods

Solar Foods is planning a listing on the Nasdaq First North Growth Market Finland marketplace

Return on capital (ROE, ROI, ROIC, RONIC)

Orion

Clinical phases of drug development